Skip to Content

MedCann Industries Inc NSRS

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock Our Analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NSRS is trading at a 32% discount.
Price
$0.00
Fair Value
$3.36
Uncertainty
Extreme
1-Star Price
$8.31
5-Star Price
$3.74
Economic Moat
Tnldjtk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NSRS is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.01
Market Cap
$7.83
Volume/Avg
7,013 / 7,010

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield
Dividend Yield (Forward)
Total Yield

Company Profile

MedCann Industries Inc is focused on the evaluation, acquisition, and development of products and businesses in the mineral resource, pharmaceutical, and medical technology industries. It creates and develops a Distribution, Research, and Manufacturing Facility. It intends to manufacture and assemble Medicine, Cosmetic, Health treatment products, and drinks. Its products include Cannabis Oil.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees
1

Valuation

Metric
NSRS
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
NSRS
Quick Ratio
0.11
Current Ratio
0.11
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
NSRS
Return on Assets (Normalized)
−120.31%
Return on Equity (Normalized)
−769.37%
Return on Invested Capital (Normalized)
−153.69%
Return on Assets
No chart available

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AQtmwl$82.2 Bil
MKKGY
Merck KGaA ADRWcpnkm$75.8 Bil
HLN
Haleon PLC ADRWnjmp$38.8 Bil
RDY
Dr Reddy's Laboratories Ltd ADRHkst$11.5 Bil
VTRS
Viatris IncWsv$11.2 Bil
CTLT
Catalent IncCfszq$7.2 Bil
PRGO
Perrigo Co PLCKvc$4.2 Bil
PBH
Prestige Consumer Healthcare IncBtwmwg$2.9 Bil
CURLF
Curaleaf Holdings IncBkrz$2.6 Bil
GTBIF
Green Thumb Industries IncSnnmm$2.5 Bil